FDA
-
-
-
-
-
-
-
Helus Pharma names former Intra-Cellular president as new CEO
-
-
-
-
-
-
-
Helus Pharma reports $148M net loss, closes $50M offering
-
-
-
-
-
-
-
Helus Pharma Phase 3 MDD trial surpasses 86% enrollment
-
-
-
-
-
-
-
Helus Pharma Partners with TARA Mind to Advance Veteran Mental HealthÂ
-
-
-
-
-
-
-
Helus Pharma appoints Dr. Ken Kramer as senior VP of medical affairs
-
-
-
-
-
-
-
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
-
-
-
-
-
-
-
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
329,984 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

